Wegovy India Launch: Comprehensive Study Guide

 Wegovy India Launch: Comprehensive Study Guide

I. Quiz

1.     What is the primary indication for Wegovy's launch in India, as stated by Novo Nordisk?

2.     How is Wegovy administered, and what type of device is used for its delivery?

3.     What are the five different dosing strengths available for Wegovy?

4.     What specific cardiovascular benefit has Wegovy been proven to offer, according to company statements?

5.     What percentage of body weight loss has been observed in at least one in three people using Wegovy alongside lifestyle changes?

6.     How does Novo Nordisk address the pricing for the initial dose levels of Wegovy in India?

7.     Which other pharmaceutical company recently launched a competing drug for diabetes and obesity management in India, and what is the name of their drug?

8.     According to national health data, what approximate percentage of Indian men and women live with obesity?

9.     What is Vikrant Shrotriya's role at Novo Nordisk India, and what is his perspective on obesity?

10.Is Wegovy available over-the-counter, or does it require a prescription?

2. Quiz Answer Key

1.     The primary indication for Wegovy's launch in India is chronic weight management and the reduction of major adverse cardiovascular events (MACE) in individuals with obesity.

2.     Wegovy is administered as a once-weekly injectable therapy. It is delivered using an easy-to-use injection pen device.

3.     The five dosing strengths for Wegovy are 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and a maintenance dose of 2.4 mg.

4.     Wegovy has been proven to lower the risk of heart attacks, strokes, and related deaths by 20% in people who already have heart disease and obesity.

5.     At least one in three people using Wegovy along with lifestyle changes may lose over 20% of their body weight.

6.     Novo Nordisk has kept the price of the first three dose levels (0.25 mg, 0.5 mg, 1 mg) the same to help patients adjust their dosage without extra cost.

7.     Eli Lilly and Company recently launched its diabetes and obesity management drug, Mounjaro (tirzepatide), in India.

8.     Approximately 24% of Indian women and 23% of Indian men live with obesity, according to national health data.

9.     Vikrant Shrotriya is the managing director of Novo Nordisk India. He states that "Obesity is a long-term health condition that needs medical support."

10.Wegovy is a prescription-only medicine and must be used under medical supervision.

3. Glossary of Key Terms

• Wegovy (semaglutide 2.4 mg): A once-weekly injectable weight management therapy launched by Novo Nordisk, indicated for chronic weight management and reducing the risk of major adverse cardiovascular events.
• Novo Nordisk: A global pharmaceutical company that developed and launched Wegovy.
• Obesity: A long-term health condition characterized by excessive body fat, increasing the risk of various illnesses and placing a burden on healthcare systems.
• Cardiovascular Health: Refers to the health of the heart and blood vessels. Wegovy is indicated for reducing the risk of serious cardiovascular events.
• Major Adverse Cardiovascular Events (MACE): A composite endpoint typically including non-fatal myocardial infarction (heart attack), non-fatal stroke, and cardiovascular death. Wegovy has been shown to reduce the risk of MACE.
• Weight Management: The process of adopting long-term lifestyle strategies to achieve and maintain a healthy weight. Wegovy is a clinically proven option for sustained weight loss.
• Injectable Therapy: A form of medication administered by injection. Wegovy is a once-weekly injectable.
• Pen Device: A type of auto-injector used for the administration of certain medications, designed for ease of use. Wegovy is delivered through a pen device.
• Dosing Strengths: The different amounts of a drug available in a single dose. Wegovy comes in five different dosing strengths.
• Mounjaro (tirzepatide): Another diabetes and obesity management drug launched by American pharmaceutical major Eli Lilly and Company in India.
• Eli Lilly and Company: An American pharmaceutical major that launched Mounjaro.
• Prescription-only medicine: A drug that can only be obtained with a valid prescription from a licensed medical professional, indicating it requires medical supervision.
• Lifestyle Changes: Modifications to daily habits, such as diet and physical activity, often recommended in conjunction with medical treatments for conditions like obesity.